Cleton-Jansen AM - Search Results

1

The majority of 22 Dutch high-risk breast cancer families are due to either BRCA1 or BRCA2.

Peelen T, Cornelis RS, van Vliet M, Petrij-Bosch A, Cleton-Jansen AM, Meijers-Heijboer H, Klijn JG, Vasen HF, Cornelisse CJ, Devilee P. Peelen T, et al. Eur J Hum Genet. 1996;4(4):225-30. doi: 10.1159/000472203. Eur J Hum Genet. 1996. PMID: 8875189

2

At least two different regions are involved in allelic imbalance on chromosome arm 16q in breast cancer.

Cleton-Jansen AM, Moerland EW, Kuipers-Dijkshoorn NJ, Callen DF, Sutherland GR, Hansen B, Devilee P, Cornelisse CJ. Cleton-Jansen AM, et al. Genes Chromosomes Cancer. 1994 Feb;9(2):101-7. doi: 10.1002/gcc.2870090205. Genes Chromosomes Cancer. 1994. PMID: 7513539

3

Loss of heterozygosity in sporadic breast tumours at the BRCA2 locus on chromosome 13q12-q13.

Cleton-Jansen AM, Collins N, Lakhani SR, Weissenbach J, Devilee P, Cornelisse CJ, Stratton MR. Cleton-Jansen AM, et al. Br J Cancer. 1995 Nov;72(5):1241-4. doi: 10.1038/bjc.1995.493. Br J Cancer. 1995. PMID: 7577475 Free PMC article.

4

Mapping of the breast basic conserved gene (D16S444E) to human chromosome band 16q24.3.

Cleton-Jansen AM, Moerland HW, Callen DF, Doggett NA, Devilee P, Cornelisse CJ. Cleton-Jansen AM, et al. Cytogenet Cell Genet. 1995;68(1-2):49-51. doi: 10.1159/000133886. Cytogenet Cell Genet. 1995. PMID: 7956357

5

Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.

Cornelis RS, van Vliet M, Vos CB, Cleton-Jansen AM, van de Vijver MJ, Peterse JL, Khan PM, Børresen AL, Cornelisse CJ, Devilee P. Cornelis RS, et al. Cancer Res. 1994 Aug 1;54(15):4200-6. Cancer Res. 1994. PMID: 8033152

6

Evidence for limited molecular genetic heterogeneity as defined by allelotyping and clonal analysis in nine metastatic breast carcinomas.

Bonsing BA, Devilee P, Cleton-Jansen AM, Kuipers-Dijkshoorn N, Fleuren GJ, Cornelisse CJ. Bonsing BA, et al. Cancer Res. 1993 Aug 15;53(16):3804-11. Cancer Res. 1993. PMID: 8101767

7

Dinucleotide repeat polymorphism at D16S533.

Cleton-Jansen AM, Moerland HW, Vossen RH, Callen DF, Breuning MH, Devilee P. Cleton-Jansen AM, et al. Hum Mol Genet. 1994 Jan;3(1):216. doi: 10.1093/hmg/3.1.216. Hum Mol Genet. 1994. PMID: 8162043 No abstract available.

8

Instability of short tandem repeats (microsatellites) in human cancers.

Wooster R, Cleton-Jansen AM, Collins N, Mangion J, Cornelis RS, Cooper CS, Gusterson BA, Ponder BA, von Deimling A, Wiestler OD, et al. Wooster R, et al. Nat Genet. 1994 Feb;6(2):152-6. doi: 10.1038/ng0294-152. Nat Genet. 1994. PMID: 8162069

9

E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers.

Berx G, Cleton-Jansen AM, Nollet F, de Leeuw WJ, van de Vijver M, Cornelisse C, van Roy F. Berx G, et al. EMBO J. 1995 Dec 15;14(24):6107-15. doi: 10.1002/j.1460-2075.1995.tb00301.x. EMBO J. 1995. PMID: 8557030 Free PMC article.

10

Positional cloning of the Fanconi anaemia group A gene.

Fanconi anaemia/Breast cancer consortium. Fanconi anaemia/Breast cancer consortium. Nat Genet. 1996 Nov;14(3):324-8. doi: 10.1038/ng1196-324. Nat Genet. 1996. PMID: 8896564

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

189 results

Search Page

Filters